Developing new influenza vaccines for better protection against flu
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM
This study is all about developing new flu vaccines and ways to deliver them, so people can have better protection against different types of the flu for a longer time, and it’s designed for anyone interested in improving flu prevention.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10391308 on NIH RePORTER |
What this research studies
This research focuses on creating and testing innovative influenza vaccine candidates and delivery methods to provide long-lasting and broad immunity against various strains of the flu virus. The approach includes conducting immunologic analyses to guide vaccine design, as well as performing laboratory tests to evaluate the effectiveness and safety of these vaccines. Clinical studies will also be conducted to assess how well these new vaccines work in real-world settings, ultimately aiming to improve flu prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received the current standard flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective influenza vaccines that provide better protection against multiple strains of the virus.
How similar studies have performed: Previous research has shown promise in developing innovative vaccine strategies, indicating that this approach has the potential for success.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.